Tate Leah 4
4 · BELDEN INC. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
BELDEN INC.BDC
Tate Leah
EVP - Chief Peop/Strat Officer
Transactions
- Sale
Common Stock
2025-02-25$111.76/sh−164$18,329→ 22,567 total - Exercise/Conversion
Stock Appreciation Rights
2025-02-24−441→ 0 totalExercise: $53.79From: 2023-02-22Exp: 2032-02-22→ Common Stock (441 underlying) - Tax Payment
Common Stock
2025-02-21−435→ 22,808 total - Exercise/Conversion
Common Stock
2025-02-24$53.79/sh+441$23,721→ 23,008 total - Tax Payment
Common Stock
2025-02-24−241→ 22,567 total - Disposition to Issuer
Common Stock
2025-02-24$111.09/sh−277$30,772→ 22,731 total
Holdings
- 1,030.108(indirect: By 401(k))
Common Stock
- 3,360(indirect: By Spouse)
Common Stock
Footnotes (6)
- [F1]Shares withheld for tax purposes related to portion of February 21, 2024 restricted stock unit grant that vested on February 21, 2025.
- [F2]Shares withheld for tax purposes related to February 22, 2022 restricted stock unit grant that vested on February 24, 2025.
- [F3]Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
- [F4]The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.
- [F5]This represents the difference between the number of SARs exercised (441) and the number of shares issued as a result of the exercise (164). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($111.09) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
- [F6]The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.